Kelly C Young-Wolff1,2, Varada Sarovar1, Daniella Klebaner1, Felicia Chi1, Brigid McCaw3. 1. Division of Research, Kaiser Permanente Northern California, Oakland. 2. Department of Psychiatry, University of California, San Francisco, San Francisco. 3. Family Violence Prevention Program, Kaiser Permanente, Oakland, CA.
Abstract
INTRODUCTION: Sexual assault (SA) is alarmingly common and is associated with higher prevalence of psychiatric and medical conditions. However, many prior studies are limited to cross-sectional designs. Health care systems with electronic health records provide unique longitudinal data to examine whether SA is associated with changes in health and health care utilization. METHODS: The sample included 1350 Kaiser Permanente Northern California adult female patients with a SA diagnosis from 2009 to 2015 and 4050 adult female patients without a SA diagnosis, matched on age, medical facility, and continuous enrollment during the study period. Using a retrospective cohort design, we tested whether a SA diagnosis was associated with 12-month changes in psychiatric and medical comorbidities and health care utilization using difference-in-difference models. Analyses were conducted in 2017. RESULTS: Patients with a SA diagnosis had a higher prevalence of psychiatric and medical comorbidities and greater health care utilization than matched patients without SA in the 12 months before the SA diagnosis, and greater increases in the prevalence of psychiatric disorders and stress-related somatic conditions, and psychiatry and obstetrics/gynecology utilization (all P<0.001), 12 months after the SA diagnosis, relative to matched non-SA patients during this time. DISCUSSION: SA is associated with increases in psychiatric disorders and stress-related somatic conditions as well as increases in utilization of psychiatry and obstetrics/gynecology. Clinicians should be trained in how to inquire about, respond to, and refer women who have experienced SA.
INTRODUCTION: Sexual assault (SA) is alarmingly common and is associated with higher prevalence of psychiatric and medical conditions. However, many prior studies are limited to cross-sectional designs. Health care systems with electronic health records provide unique longitudinal data to examine whether SA is associated with changes in health and health care utilization. METHODS: The sample included 1350 Kaiser Permanente Northern California adult female patients with a SA diagnosis from 2009 to 2015 and 4050 adult female patients without a SA diagnosis, matched on age, medical facility, and continuous enrollment during the study period. Using a retrospective cohort design, we tested whether a SA diagnosis was associated with 12-month changes in psychiatric and medical comorbidities and health care utilization using difference-in-difference models. Analyses were conducted in 2017. RESULTS:Patients with a SA diagnosis had a higher prevalence of psychiatric and medical comorbidities and greater health care utilization than matched patients without SA in the 12 months before the SA diagnosis, and greater increases in the prevalence of psychiatric disorders and stress-related somatic conditions, and psychiatry and obstetrics/gynecology utilization (all P<0.001), 12 months after the SA diagnosis, relative to matched non-SA patients during this time. DISCUSSION: SA is associated with increases in psychiatric disorders and stress-related somatic conditions as well as increases in utilization of psychiatry and obstetrics/gynecology. Clinicians should be trained in how to inquire about, respond to, and refer women who have experienced SA.
Authors: Nicole A Short; Megan Lechner; Benjamin S McLean; Andrew S Tungate; Jenny Black; Jennie A Buchanan; Rhiannon Reese; Jeffrey D Ho; Gordon D Reed; Melissa A Platt; Ralph J Riviello; Catherine H Rossi; Patricia P Nouhan; Carolyn A Phillips; Sandra L Martin; Israel Liberzon; Sheila A M Rauch; Kenneth A Bollen; Ronald C Kessler; Samuel A McLean Journal: Depress Anxiety Date: 2020-10-08 Impact factor: 6.505
Authors: Gita Rajan; Sanna Syding; Gunnar Ljunggren; Per Wändell; Lars Wahlström; Björn Philips; Carl Göran Svedin; Axel C Carlsson Journal: Eur Child Adolesc Psychiatry Date: 2020-11-01 Impact factor: 4.785